CLINICAL_TRIALS
ClinicalTrials.gov record update
Safety and Reactogenicity of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib) in Infants
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00964028
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:54.771931+00:00
- Published At
- 2017-04-10T00:00:00+00:00
- Record Updated At
- 2018-06-06
- Results Posted At
- 2017-04-10
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Haemophilus Influenzae Type b", "Acellular Pertussis", "Diphtheria", "Tetanus", "Poliomyelitis"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-06-06"- protocolSection.identificationModule.nctId
"NCT00964028"- protocolSection.identificationModule.officialTitle
"Safety and Reactogenicity of GSK Biologicals\u0027 DTPa-IPV/Hib (Infanrix\u2122-IPV/Hib) in Infants"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-04-10"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.